Skip to main content
. 2022 Jul 6;62(2):872–885. doi: 10.1093/rheumatology/keac385

Fig. 4.

Fig. 4

IκBζ mediates regulation of ELF3 gene expression

(A) HEK293 cells were transfected with plasmid coding for IκBζ or with empty vector and after 48h the cells were stimulated for 24h with TNF (10ng/ml) or left untreated. ELF3 mRNA expression was analysed by qRT-PCR. (B) HEK293 cells were transfected with plasmid coding for IκBζ or with empty vector in combination with ELF3 reporter plasmid. After 48h the cells were stimulated for 24h with TNF (10ng/ml) or left untreated. ELF3 promoter activity was determined with dual-luciferase assay. (C and D) OA synovial fibroblasts were transfected with targeting siRNA or with negative control siRNA. After 48h cells were stimulated for 24h with IL-17A (50ng/ml) and/or TNF (10ng/ml). (C) The effect of IκBζ silencing on ELF3 mRNA expression. (D) The effect of C/EBPβ silencing on ELF3 mRNA expression. Data in (A, B) represent means ± SEM of five (A) and three (B) individual experiments. Data in (C, D) represent means ± SEM of four (C) and three (D) individual experiments with cells from different donors. *P <0.05, **P <0.01, ***P < 0.001. C/EBPβ: CCAAT/enhancer-binding protein β; ELF3: E74-like factor-3; IκBζ: NF-κB inhibitor-ζ; RLU: relative light units.